![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 19156-19165, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, January 11, 2002, and in revised form, February 8, 2002
The human DNA-binding HSAkin17
protein cross-reacts with antibodies raised against the
stress-activated Escherichia coli RecA protein. We show
here that HSAkin17 protein is directly associated with
chromosomal DNA as judged by cross-linking experiments on living cells.
We detected increased amounts of DNA-bound HSAkin17 protein
24 h after Ionizing radiation (IR)1
induces a large range of DNA damage, including DNA double-strand breaks
(DSBs), which represent a major threat to the integrity of mammalian
genomes through chromosomal breakages and rearrangements (1). In
mammalian cells, DSBs are repaired either by the homologous
recombinational repair or by nonhomologous end joining (2, 3). DSB
repair pathways are usually characterized by the sequestration of many
factors into discrete nuclear foci at the sites of DNA lesions and
until completion of DSB repair (4). Some of the proteins belonging to
these pathways act as a sensor for DNA damage or are involved in cell
cycle checkpoints. This is the case for the histone H2AX, 53BP1, RPA,
Rad51, BRCA1, or the Mre11-Rad50-Nbs1 nuclease complex (4-8). For
instance, the tumor suppressor gene BRCA1, previously involved in the regulation of the replication checkpoint and
transcription-coupled repair, forms a multiprotein complex with
Mre11-Rad50-Nbs1 and other proteins following irradiation, termed as
BASC (BRCA1-associated surveillance
complex), which may serve as a sensor of DNA lesions (8,
9).
In this cascade of IR-induced proteins forming nuclear foci, we
characterized here the HSAkin17 protein. Murine
MMUkin17 protein was identified on the basis of a
cross-reactivity with antibodies raised against the Escherichia
coli RecA protein, a key enzyme in homologous recombination and
recombinational repair of damaged DNA (10, 11). This cross-reactivity
stemmed from a sequence homology stretching over 39 amino acids
highly conserved during evolution (12). This domain is located in
the carboxyl-terminal region of the E. coli RecA protein, a
region involved in the regulation of DNA binding (13). Recent data show
that kin17 proteins are highly conserved during
evolution.2 In particular, a
homologous protein has been identified in the yeast
Schizosaccharomyces pombe. This conservation from yeast to
human points to an essential role of kin17 proteins. For instance, the
expression of kin17 proteins is preserved in the phylogeny of the brain
of higher vertebrates (14, 15). To date, major features of the kin17
protein are its abilities (i) to bind in vitro to
double-stranded DNA and preferentially to DNA with a curved
topology stretching over illegitimate recombination junctions (16, 17),
(ii) to complement the functions of the H-NS (histone-like nucleoid structure) protein transcription
factor in deficient bacterial strains in controlling gene expression
(18), and (iii) to be a stress-activated protein recruited during the
cellular response to ionizing radiation or UVC (19, 20). In particular, UVC irradiation induced a stabilization of MMUKIN17
mRNA from 80 min to more than 8 h in mouse fibroblasts (21).
Interestingly, In human cells, the HSAKIN17 gene is localized on
chromosome 10 at position p15-p14. HSAKIN17
transcripts were ubiquitously found at low levels in all human organs
tested, displaying an expression profile akin to that of housekeeping genes. Heart, skeletal muscle, and testis displayed the highest HSAKIN17 mRNA levels compared with the other
tissues analyzed (12). HSAkin17 protein expression is
associated with the differentiation program of human keratinocytes
cultivated in the in vitro reconstructed skin model (22).
Mouse and human kin17 proteins are able to arrest cell proliferation of
human tumor cells when their expression is transiently increased after transfection (23).3 Only the
immortalized but not tumorigenic HEK 293 cell line tolerates ectopic
expression of either MMUkin17 or HSAkin17
proteins and can be propagated in mass culture for several weeks.
However, the constitutive overexpression of MMUkin17
protein in HEK 293 cells entailed major growth defects and nuclear
abnormalities (23).
We show here for the first time that the HSAkin17 protein
is mainly present in the nuclear compartment associated with nuclear structures in human cells. We demonstrate that a fraction of nuclear HSAkin17 protein is directly associated with DNA.
HSAkin17 protein is localized in discrete nuclear foci
spread throughout the nucleoplasm. Strikingly, Cell Cultures--
Human colorectal carcinoma RKO cells were
obtained from M. F. Poupon. Human cervical carcinoma HeLa cells
were obtained from E. May. The cell lines were maintained in
Dulbecco's modified Eagle's medium (Invitrogen) supplemented with
10% fetal calf serum, 100 units/ml of penicillin, and 100 µg/ml of
streptomycin, under 5% CO2.
Cloning of EBV vectors carrying HSAKIN17 cDNA in
an antisense orientation has been performed as described elsewhere (23). Transfected RKO cells carrying EBV plasmids were propagated in
culture in the presence of 500 µg/ml hygromycin B (Invitrogen). We
used the following vectors: pEBVCMV (pB482) and
pEBVCMVasHSAKin17 (pB399as). Transfection experiments were
carried out using LipofectAMINE 2000 (Invitrogen). RKO clones
transfected with the pB399as EBV vector carrying the
HSAKIN17 cDNA-SV40 polyadenylation signal
cartridge in an antisense orientation were termed RASK, for
RKO antisense
HSAKIN17 cDNA. Control
clones carrying the pB482 plasmid were named R482.
The cells were irradiated using a 137Cs source (IBL 637 CisBio International) with a dose rate of 1.97 Gy/min. For clonogenic cell growth, the RKO cells were seeded as indicated in the table and
cultivated for 2 weeks in the presence of hygromycin B. Growing clones
were fixed with 4% paraformaldehyde and stained with methylene blue,
and the clones containing more than 50 cells were counted. Each
experiment was done three times.
Monoclonal Antibodies against HSAkin17 Protein and
ELISA--
Monoclonal antibodies (mAb K3, mAb K31, mAb K36, and mAb
K58) were obtained after inoculation of recombinant His-tagged human HSAkin17 protein (His6-HSAkin17)
purified by metal chelation and heparin column chromatography from
baculovirus-infected Sf9 Spodoptera frugiperda cell
extracts and injected in mice as described
previously.4 We used either
hybridoma supernatants (mAb K36) or IgG anti-HSAkin17 protein (Ig K36; Ig K58) purified from ascites fluid. Purified immunoglobulin from rabbit polyclonal antibody
anti-His6-HSAkin17 (IgG 77P) was obtained as
described elsewhere.4
A conventional two-site immunometric assay (sandwich immunoassay) based
on two specific monoclonal antibodies recognizing nonoverlapping
epitopes was developed essentially as described by Grassi et
al. (24). We chose the mAb K3 and mAb K31 monoclonal antibodies,
the mAb K3 being conjugated to acetylcholinesterase as reporter enzyme
(24).
Indirect Immunofluorescence Staining--
The cells were plated
at 5,000 cells/cm2 on glass coverslips and treated. At
the indicated times after treatment, the cells were fixed for 5 min in
70% acetone, 30% methanol at Protein Extraction and Western Blot--
The cells were seeded
at 5,000 cells/cm2 3 days before trypsinization and treated
as indicated. The cells were lysed using RIPA buffer (50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 1% IgepalTM,
0.1% SDS, 0.1% sodium deoxycholate, protease inhibitor mixture from
Roche Molecular Biochemicals) or buffer N (50 mM Tris-HCl, pH 7.9, 150 mM NaCl, 1% IgepalTM, 1 mM EDTA, protease inhibitor mixture from Roche Molecular
Biochemicals), as indicated in the legends of the figures. The lysates
were kept on ice for 30 min with the buffer N, and soluble proteins
recovered after centrifugation (20,000 × g for 15 min)
were quantified by Bradford assay (Bio-Rad) and analyzed by ELISA or
Western blot. The remaining pellets were denatured in Laemmli sample
buffer, boiled for 10 min at 100 °C, and analyzed by Western blot.
Purified IgG Ig K36 and Ig K58 were used at a concentration of 25 ng/ml. Other antibodies used were anti-p53 protein (hybridoma supernatant mAb DO-7 antibody diluted to 1:2000). DO-7 antibody was
kindly provided by Dr. E. May. Anti-PCNA (mouse monoclonal PC10
antibody diluted to 50 pg/ml; Novo Castra) and anti-RPA70 (25 ng/ml)
were also used.
In Vivo Cross-linking and Preparation of DNA-Protein
Complexes--
The procedure has been described by Göhring and
Fackelmayer (25). Briefly, HeLa cells were washed once with PBS and
incubated for 3 min at 37 °C in Dulbecco's modified Eagle's medium
(without serum) containing 1% formaldehyde. Cross-linked cells were
recovered by centrifugation (5 min at 750 × g). The
cells were resuspended in buffer RSB (10 mM Tris-HCl, 10 mM NaCl, and 3 mM MgCl2, pH 8.0)
and homogenized in a chilled Dounce homogenizer. The nuclei were
collected by centrifugation (8 min, 750 × g), and the
unbound proteins were extracted in buffer E (10 mM
Tris-HCl, 10 mM
Na2S2O5, 1 M NaCl,
0.1% IgepalTM, 1 mM EDTA-KOH, and 0.5 mM phenylmethylsulfonyl fluoride, pH 8.0). After
extraction, the nuclei were pelleted as above, resuspended in 0.1 M NaCl, and lysed at a final concentration of 2% sodium sarkosyl. The samples were layered on a preformed CsCl step gradient (3 ml of 1.75 g/ml CsCl solution, 3.5 ml of 1.5 g/ml CsCl solution, and 3 ml of 1.3 g/ml CsCl solution). All CsCl solutions were prepared in 20 mM Tris-HCl, 1 mM EDTA-KOH, and 0.5%
sodium sarkosyl. After centrifugation for 24 h at 200,000 × g at 20 °C and fractionation from the top, DNA-protein
complexes sediment at a density of ~1.3 g/ml. Aliquots of the
fractions were sonicated, and the density of individual fractions was
determined. For RNase digestion, the pooled fractions were dialyzed
against 20 mM Tris-HCl, pH 8.0, 50 mM NaCl, and
2 mM EDTA before 5 µg of DNase-free RNase was added for
30 min at room temperature. Solid CsCl was added to a density of 1.5 g/ml in a final volume of 5 ml, and the sample was recentrifuged for
72 h at 250,000 × g at 20 °C. The gradient was
fractionated and analyzed. The DNA-containing fraction was briefly
sonicated and desalted by gel filtration on Sephadex G25 columns.
Cross-links were cleaved by incubation at 100 °C for 10 min in
Laemmli sample buffer and analyzed on SDS-polyacrylamide gels.
Additional dimethylsulfate (DMS) treatment was done after the second
CsCl gradient as follows. The DNA-containing fraction was sheared by
sonication and then desalted over a Sephadex G25 column into 30 mM sodium phosphate, pH 7.4, 2.5 mM EDTA, 2.5 mM EGTA. After desalting, Flow Cytometry Analysis of BrdUrd Incorporation--
The cells
were plated at a density of 5,000 (control R482) or 10,000 (RASK)
cells/cm2 3 days before irradiation. 24 h later, the
cells were pulse-labeled with 30 µM BrdUrd for 15 min,
washed in PBS, and collected by trypsinization. The cells were
resuspended in PBS and fixed with ethanol (75%). BrdUrd-labeled cells
were detected as described by Bensaad et al. (26). Briefly,
the nuclei were isolated following treatment with pepsin 0.5% in 30 mM HCl for 20 min, and cellular DNA was partially denatured
with 2 N HCl for 20 min at 37 °C. After extensive
washing, the cells were incubated successively with rat anti-BrdUrd
antibodies for 1 h at room temperature and with fluorescein
isothiocyanate-conjugated goat anti-rat IgG secondary antibody for 30 min at room temperature. Then they were washed again twice in PBS and
stained with 25 µg/ml propidium iodide for 20 min at room
temperature. The data were collected using a FACsort flow cytometer (BD PharMingen).
Association of Human HSAkin17 Protein with Chromosomal
DNA in Vivo--
Mazin et al. (16, 17) demonstrated that
in vitro mouse MMUkin17 protein recognizes DNA,
particularly double-stranded DNA with a curved topology. In
agreement with these results, we have observed that most
HSAkin17 protein was localized in nuclei of different
cultured human cell lines (data not shown). We then tested whether
in vivo endogenous human HSAkin17 protein could be associated with chromosomal DNA. We used a method based on a limited
cross-linking of living HeLa cells with formaldehyde to stabilize
DNA-protein interactions prior to the extraction (25). This method
minimized the formation of nonspecific cross-links and further
excluded noncross-linked material by two consecutive cesium chloride
density gradient centrifugations. Equilibrium density gradient
centrifugation separates cellular components according to their
density. Under these experimental conditions, DNA-protein complexes
exhibited a density near to that of native chromatin (1.4 g/ml).
Covalent bonds introduced by formaldehyde are reversible by boiling in
SDS-containing buffers, thus allowing the analysis of proteins by
SDS-PAGE. After a first centrifugation, we observed a co-migration of
HSAkin17 and PCNA proteins as components of a high
molecular weight complex displaying similar densities (Fig.
1A). Fractions 6-8 containing
DNA were pooled and purified by a second isopycnic centrifugation. Most
HSAkin17 protein was detected in fractions corresponding to
DNA-protein complexes, suggesting that HSAkin17 protein was
bound in vivo to DNA in HeLa cells (Fig. 1B).
We asked whether HSAkin17 protein is associated with the
chromatin in a cell cycle-dependent manner. HeLa cells were
treated with a microtubule poison (nocodazole) to trigger an anaphase arrest and to trap cells into mitosis (27). HeLa cells arrested in
G2-M retained HSAkin17 tightly associated with
the chromatin structure, as did mock treated cells (Fig.
1C). Therefore, HSAkin17 remains associated
with the chromatin structure in both proliferating or
G2-M-arrested cells. Hence, in vivo
association of HSAkin17 protein with DNA structures was
independent of the cell cycle.
We next examined whether HSAkin17 protein was directly
bound to DNA. We used DMS to convert heat-reversible methylene
bonds induced by formaldehyde to stable DNA-protein covalent bonds that are resistant to boiling in SDS-containing buffers. Under these conditions, if HSAkin17 protein is directly associated
with the chromatin, the DNA-protein complex is stabilized and cannot be separated by SDS-PAGE. Conversely, if HSAkin17 protein
is linked to proteins of the chromatin, covalent methylene bonds are
reversed by boiling, and the protein can migrate in SDS-PAGE. After DMS treatment the HSAkin17 band disappeared, showing that
in vivo most Hskin17 protein is directly linked
to DNA (Fig. 1D, lane 2).
Second, we assessed the level of HSAkin17 protein
anchored to the DNA structure 24 h after IR. In this approach, we
used a lysis buffer containing 1% IgepalTM (buffer N) to
discriminate between cytoplasmic and soluble nuclear proteins
(detergent-soluble fraction) and nuclear proteins highly anchored to
DNA (DNA-bound fraction). We observed a dose-dependent increase in the DNA-bound HSAkin17 protein levels 24 h
after
To confirm that IR increased the level of HSAkin17 protein
tightly associated with DNA, the proteins were recovered with buffer N
containing increased ionic strengths (0.15, 0.5, or 1 M
NaCl), and the amount of HSAkin17 protein in the
detergent-soluble fraction was quantified by ELISA. To quantify the
amount of HSAkin17 protein/cell, we used a two-site
immunometric assay (sandwich immunoassay) based on two monoclonal
antibodies (24). HSAkin17 recombinant protein allowed us to
calibrate the ELISA (data not shown). The irradiation experiments were
performed with RKO cells and with derived clones carrying a pEBVCMV
vector (see below). We observed an enhanced recovery of the soluble
HSAkin17 protein with increased ionic strength of buffer N
(0.5 or 1 M NaCl) as compared with 0.15 M NaCl
(Fig. 2C). Considering that 100% of HSAkin17
molecules were recovered with 1 M NaCl after irradiation at
6 Gy, we obtained only 73% at 0.5 M NaCl and 35% at 0.15 M NaCl. At 1 M NaCl we reached roughly the same
percentage recovery as that obtained with an RIPA buffer. This
indicated that increased amounts of HSAkin17 tightly
associated with DNA were observed after damage to DNA (Fig.
2C). At higher ionic strength, the number of
HSAkin17 molecules increased 2.6-fold 24 h after
irradiation at 6 Gy (46,000-117,000 molecules). A similar result was
obtained with the parental RKO cell lines, implying that the expression
of the viral EBNA-1 protein did not interfere with the
HSAkin17 response (data not shown).
Localization of HSAkin17 Protein in Large Nucleoplasmic
Foci Following Isolation of RASK Cells Expressing an Antisense
HSAKIN17 Transcript--
To evaluate the importance of
foci-forming HSAkin17 protein during cell proliferation and
the cellular response to ionizing radiation, we generated several
clones displaying low levels of HSAkin17 protein.
In a first step, we analyzed endogenous HSAkin17 protein
levels in different human cells by ELISA and Western blot. We conclude that endogenous HSAkin17 protein is tightly associated with
the DNA, whatever the cell line used (data not shown). We also observed that human carcinoma cells, such as RKO cells, exhibited the greatest number of HSAkin17 molecules/cell as compared with either
normal human fibroblasts or other tumoral cells.4 For this
reason, we decided to reduce the HSAkin17 protein level in
RKO cells. RKO clones were isolated after transfection of the pEBVCMVasHSAKIN17 vector (pB399as) carrying a
HSAKIN17 cDNA-SV40 polyadenylation signal
cartridge in an antisense orientation, followed by subsequent
hygromycin B selection. These clones were termed RASK (RKO
antisense
HSAKIN17. From the 60 clones
isolated, half died rapidly, and the others grew very slowly. After
several weeks of cultivation, three RASK clones were selected and
characterized in more detail (RASK.1, RASK.5, and RASK.13). Three
clones carrying the pEBVCMV vector (pB482) were selected at random and
used as controls (R482.1, R482.2, and R482.3).
Because RASK cells expressing the antisense HSAKIN17
cDNA were usually unstable, we systematically assessed
HSAkin17 protein levels by either immunocytochemical
staining or Western blot. As judged by indirect immunofluorescence,
more than 95% of HSAkin17 protein was essentially
localized in nucleoplasmic speckles of diameters ranging from 0.1 to 2 µm in proliferating R482 cells (Fig.
4A). In highly proliferating
cells, the greater number of HSAkin17 foci inside nuclei of
R482 cells led to an intense nuclear staining. We further noted that a
few R482 cells presented the staining of an extranuclear
structure close to the nuclei (indicated by
arrows in Fig. 4A). In the parental RKO cells, we
currently detected an extranuclear structure close to the nuclei and probably in the vicinity of the nucleosome, which concentrated the
HSAkin17-specific fluorescence signal. This indicated that the expression of a viral nuclear protein (EBNA-1) coded by EBV vectors
could not account for the observed distribution of the HSAkin17 protein. Seven weeks after transfection and
hygromycin B selection, the production of antisense
HSAKIN17 mRNA in RASK cells appeared to decrease
strikingly the number of HSAkin17 nucleoplasmic foci,
leading to a weak diffuse nuclear staining (Fig. 4A).
Curiously, RASK cells maintained one or two extranuclear stained
structures/cell, suggesting that HSAkin17 protein presented here was certainly very stable (arrows in Fig.
4A).
Western blot analysis of HSAkin17 protein also revealed a
dramatic decrease in the HSAkin17 basal level (70-80%
less) in the three antisense clones selected, as compared with controls
(Fig. 4B). This reduction was specific for
HSAkin17 protein because the expression of PCNA remained
unchanged. Interestingly, RASK cells failed to induce
HSAkin17 protein 24 h after irradiation, as did
control clones. Therefore, we used RASK cells to study the biological
consequences of a reduced HSAkin17 protein content in a
human tumor cell.
Early and Mid-S Phase Accumulation of RASK Cells--
We asked
whether reduced HSAkin17 protein levels affect cell
proliferation. Plating efficiencies of the different clones were assessed after seeding the same number of control and RASK
cells/cm2. Under these culture conditions, RASK cells
exhibited a markedly decreased proliferation rate, with plating
efficiencies 15-fold lower than those observed for control clones (data
not shown). When cells were plated at different densities to account
for their specific plating efficiencies, we also observed a dramatic
decrease of growing clones in both RASK clones (Table
I). Therefore, decreased levels of
HSAkin17 protein strongly affected cell growth.
This decreased cell proliferation observed in RASK cells that express
the antisense HSAKIN17 mRNA could stem from alteration of their cell cycle. Therefore, we analyzed the cell cycle
of BrdUrd pulse-labeled RASK clones by flow cytometry analysis. The
cells were seeded 3 days before irradiation (6 Gy) and analyzed 24 h later. The cells were pulse-labeled for 15 min with 30 µM BrdUrd. Incorporation of BrdUrd into cellular DNA was
measured by fluorescence-activated cell sorter analysis, and the
percentage of BrdUrd-positive cells corresponded to S phase cells
actively synthesizing DNA (Fig.
5).
Comparison of the cell cycle of RASK cells versus
control cells revealed a low number of RASK.5 cells in the
G1 phase (45 ± 2%) as compared with control (65 ± 2%) and an enhanced proportion of BrdUrd-positive cells with a DNA
content between 2 and 4 N (34 ± 1% versus
24 ± 2%) (Fig. 5 and Table II).
RASK.5 cells accumulated in early and mid-S phase, but only a few cells
were detected in late S phase (Fig. 5C). This suggested that
low HSAkin17 protein levels resulted in better entry into
the S phase, but replicating cells were hampered in their progress to
the S phase. We also detected an elevated percentage of cells in the
G2 phase (20 ± 1%) as compared with control cells
(12 ± 1%). We obtained similar results using RASK.13 cells (data
not shown). These cell cycle modifications could explain the reduced
proliferation rates observed in the RASK cells. R482.1 cells and RASK.5
cells displayed a G2 arrest 24 h after 6 Gy, with
65 ± 9% and 61 ± 4% of cells in G2 phase,
respectively, indicating that HSAkin17 protein is not
essential for the Endogenous HSAkin17 Co-localized with the RPA Protein
24 h after Irradiation--
Because HSAkin17 is (i)
associated with DNA and (ii) induced after IR at later times
post-irradiation (24 h), we hypothesized that after irradiation
HSAkin17 protein could be associated with remaining DNA
lesions. This prompted us to compare the intracellular localization of
HSAkin17 with a protein known to participate in the DNA
repair processes.
In mock-irradiated proliferating RKO cells, RPA was uniformly
distributed throughout the nucleoplasm as a dispersed and punctate pattern that corresponds to replication foci (Fig.
6A). After The well conserved kin17 proteins are DNA-binding proteins
activated in response to ionizing and UVC irradiations (19, 20). Prior
studies were mainly performed at the mRNA level. Recently, the
production of large amounts of human recombinant HSAkin17 protein made it possible to obtain a panel of new monoclonal antibodies and to develop biochemical approaches. This also affords us the opportunity to quantify endogenous HSAkin17 protein levels
in different human cells using ELISA. Normal, immortalized, or tumoral cells present a wide range of HSAkin17 protein levels.
Although proliferating normal human fibroblasts elicited a low level,
non-small cell lung carcinoma cells (H1299) and colorectal carcinoma
cells (RKO) display the highest level.5 Therefore,
high HSAkin17 protein levels are observed during
carcinogenesis that may be a consequence of uncontrolled proliferation
or genomic instability. Alternatively, elevated levels could be
required during the process of cancer development. Immunocytochemical
staining performed with the mAb K36 antibody identified
HSAkin17 as a protein mainly localized in nuclei with a
staining pattern resembling those observed for other proteins involved
in DNA replication. This observation is consistent with the previously
reported localization of kin17 protein in HeLa cells using antibodies
directed against the mouse MMUkin17 protein and raised in
rabbits (12). Interestingly, certain tumor-derived cells concentrate a
part of the HSAkin17 protein in a dense fluorescence focus
neighboring to the nucleus, particularly in resting cells. At present,
we have no explanation for this observation.
We identify here HSAkin17 as a protein tightly associated
in vivo with the chromosomal DNA. We show that
HSAkin17 protein exists in the cells as both a soluble
fraction and a DNA-bound fraction. Other nuclear proteins involved in
the DNA metabolism, such as PCNA, exhibited a similar distribution. IR
triggers a redistribution of HSAkin17 protein from a
soluble form to DNA-bound complexes comparable with that observed for
PCNA (28). However, whereas an increased level of the PCNA
insoluble fraction was observed at higher doses of irradiation
(e.g. 10 Gy in our experiment), the DNA-bound
HSAkin17 fraction increases at a lower dose (0.5 Gy).
This enhanced amount of HSAkin17 bound to DNA observed
after irradiation coincides with the appearance of large intranuclear focal sites of HSAkin17 scattered throughout the nucleus.
We show that HSAkin17 and RPA proteins co-localized in
large foci 24 h after irradiation at 6 Gy. IR-induced
RPA/HSAkin17 foci were observed only in highly
proliferating cells, suggesting that DNA replication is required.
The heterotrimeric RPA protein is a single-stranded DNA-binding
protein required for DNA replication, recombination, nucleotide excision repair, DSB repair, and transcriptional regulation (29). RPA
is a crucial component of the early stage of nucleotide excision repair, because it binds synergistically with XPA to damaged
single-strand DNA, allowing the subsequent recruitment of the other
repair factors at the site of DNA damage (30, 31). RPA is also involved
in the gap-filling step of nucleotide excision repair, which requires PCNA, RF-C, and DNA polymerase If HSAkin17 protein acts at the site of DNA
replication, in particular of damaged DNA, a lowered
HSAkin17 protein level might impede cell proliferation and
decrease resistance to IR. The antisense strategy used here to
constitutively decrease the HSAkin17 protein level
confirmed this idea. The overexpression of an antisense HSAKIN17 transcript led to a 75% decrease in the
HSAkin17 protein level, which correlates with a reduced
cell growth and increased
radiosensitivity.6 Flow
cytometry analysis of BrdUrd incorporation showed an accumulation of
HSAkin17 antisense cells in early and mid-S phase and a
subsequent increase in the number of cells in the G2 phase.
The increased number of cells in the G2 phase may
correspond to RASK cells undergoing DNA repair. We hypothesized that a
premature entry of RASK cells into the S phase, as evidenced by the low
number of cells in the G1 phase, may lead to an
accumulation of DNA damage and a subsequent arrest in the
G2 phase. The accumulation of RASK cells in early and mid-S
phase indicates that HSAkin17 protein participates in DNA replication. Indeed, ongoing experiments revealed that
HSAkin17 protein co-purifies with RPA and PCNA proteins in
elution fractions corresponding to DNA replication
complexes.5
Our results show that human PCNA and HSAkin17
proteins are components of the same set of replication proteins
activated by ionizing radiation. The decrease in the intracellular
concentration of HSAkin17 protein affects the cell cycle,
apparently by interfering with proteins localized at damaged DNA sites
unable to replicate. The RASK cells described here compared with other
human cells unable to repair double-strand breaks will be used to test
this idea further and to shed some light on the molecular role played by the human HSAkin17 protein.
We are indebted to J. Grassi for advice and
support and to M. Plaisance, P. Lamourette, and M. C. Nevers for
efficient help in producing monoclonal antibodies and setting up the
ELISA. We are grateful to D. Rouillard (Institut Curie) for having
kindly performed the flow cytometry analysis of BrdUrd-labeled cells. D. Biard is grateful to M. F. Poupon and E. May for cell lines and antibodies.
*
This work was supported by Electricité de France
Contract 8702.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: CEA-DSV-DRR,
Laboratoire de Génétique de la Radiosensibilité, BP
6, 92265 Fontenay aux Roses, France. E-mail:
biard@dsvidf.cea.fr.
Published, JBC Papers in Press, March 5, 2002, DOI 10.1074/jbc.M200321200
2
J. F. Angulo, unpublished result.
3
D. S. F. Biard, unpublished data.
4
L. Miccoli, D. S. F. Biard, C. Créminon,
and J. F. Angulo, submitted for publication.
5
L. Miccoli, D. S. F. Biard, and A. J. F. Angulo, manuscript in preparation.
6
E. Despras, L. Niccoli, C. Créminon, J. F. Angulo, and D. S. F. Biard, submitted for publication.
The abbreviations used are:
IR, ionizing
radiation;
DSB, double-strand break;
RPA, replication protein A;
EBV, Epstein-Barr virus;
Gy, gray;
ELISA, enzyme-linked immunosorbent
assay;
mAb, monoclonal antibody;
PBS, phosphate-buffered saline;
DMS, dimethylsulfate;
BrdUrd, bromodeoxyuridine;
PCNA, proliferating
cell nuclear antigen.
Ionizing Radiation Triggers Chromatin-bound kin17 Complex
Formation in Human Cells*
§,
,
,
Commissariat à l'Energie Atomique,
Laboratoire de Génétique de la Radiosensibilité,
Département de Radiobiologie et de Radiopathologie, Direction des
Sciences du Vivant, Fontenay-aux-Roses 92265, France and the
¶ Commissariat à l'Energie Atomique, Service de
Pharmacologie et d'Immunologie, Département de Recherche
Médicale, Direction des Sciences du Vivant, CE Saclay, Gif sur
Yvette 91191, France
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
irradiation, with 2.6-fold more
HSAkin17 molecules after 6 Gy of irradiation
(46,000-117,000 molecules). At this time we observed that highly
proliferating RKO cells displayed the concentration and co-localization
of HSAkin17 and replication protein A in
nucleoplasmic foci. Our results suggest that 24 h post-irradiation
HSAkin17 protein may localize at the sites of unrepaired
DNA damages. RKO clones expressing an HSAKIN17 antisense transcript (RASK.5 and RASK.13 cells) revealed that reduced
HSAkin17 protein levels are correlated with a decrease in
clonogenic cell growth and cell proliferation, as well as an accumulation of cells in early and mid-S phase. Taken together our
observations support the idea that HSAkin17 protein is a
DNA maintenance protein involved in the cellular response to the
presence of DNA damage and suggest that it helps to overcome the
perturbation of DNA replication produced by unrepaired lesions.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
XPA mouse cells, which are unable to repair
UVC-induced DNA damage, accumulated MMUKIN17
mRNA at lower doses of UVC (5-10 J/m2) than
repair-proficient mouse fibroblasts (20-30 J/m2),
suggesting that DNA damage per se is required for the
stabilization of MMUKIN17 mRNA (21).
irradiation induces
an increase in the DNA-bound fraction of HSAkin17 protein
that correlates with the appearance of foci containing both
HSAkin17 protein and replication protein A (RPA) 24 h
after IR. To ascertain the requirement of HSAkin17 in the
immortalized phenotype, we have expressed
HSAKIN17 antisense transcript in RKO carcinoma
cells. These RKO cells expressing the antisense
HSAKIN17 (called RASK cells) displayed markedly
reduced proliferation rates associated with a defect in S phase
progression. All of our observations support the idea that
HSAkin17 protein is involved in the cellular response to the presence of DNA damage and suggest that it may help to overcome the
DNA replication arrest produced by unrepaired lesions.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
20 °C. The primary antibodies were
diluted in the incubation buffer B (0.5% Tween 20, 12% bovine serum
albumin, 0.036% NaN3 in PBS) and incubated for 45 min. The
following antibodies were used: hybridoma supernatant mAb K36
anti-HSAkin17 (diluted by half), purified Ig K36
anti-HSAkin17 (450 ng/ml), purified rabbit immunoglobulin
IgG 77P against HSAkin17 (5 µg/ml), and anti-RPA70
(directed against the 70-kDA subunit; mouse monoclonal NA13
antibody, 500 ng/ml; Oncogene Research Products). Primary antibodies
were revealed with either Cy2TM-conjugated
affinity-purified goat anti-mouse IgG or Cy3TM-conjugated
affinity-purified goat anti-rabbit IgG (Jackson Laboratories, Inc.; 2 µg/ml). The cells were counterstained with
4',6-diamino-2-phenylindole (4 µg/ml). Immunofluorescence staining
was viewed using a Zeiss Axiophot 2 epifluorescence microscope coupled
to a cooled Sensys 1400 camera from Photometrics monitored by the Zeiss
KS300 3.0 program. The use of a CCD camera-based imaging system allows
high resolution and a wide dynamic range for acquiring and analyzing fluorescent staining. Representative fields for each cell line are
presented. Irradiation experiments were reproduced more than 10 times
under different culture conditions.


![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (55K):
[in a new window]
Fig. 1.
HSAkin17 protein binds directly
to chromosomal DNA in vivo. In vivo cross-linking
with formaldehyde (1%, 3 min) was performed in HeLa cells. After
cross-linking, the nuclei were isolated and lysed, and DNA-protein
complexes were purified by equilibrium centrifugation in two
consecutive cesium chloride gradients. The proteins were analyzed onto
a 10% SDS-PAGE. A, purification of DNA-protein complex from
proliferating HeLa cells after the first equilibrium centrifugation
revealed both HSAkin17 and PCNA in the same fractions.
B, DNase-treated fractions 6-8 were pooled, recentrifuged
on an isopycnic cesium chloride gradient, fractionated, and analyzed as
above. C, as in B with HeLa cells treated with
0.2 µM nocodazole for 16 h. D, DMS
treatment demonstrates a direct binding of HSAkin17 to DNA.
Purified DNA-protein complexes from a second CsCl gradient were treated
with DMS according to the procedure described under "Materials and
Methods." Lane 1, mock treated cells + formaldehyde
cross-link. Lane 2, mock treated cells + formaldehyde
cross-link + DMS. Lane 3, nocodazole treated cells + formaldehyde cross-link. Lane 4, input lane
1. Lane 5, input lane 2. Lane 6,
2 ng of purified His6-HSAkin17.
Irradiation Increases the Amount of HSAkin17
Protein Bound to DNA--
Because HSAkin17 is a
chromatin-bound protein, we next asked whether
irradiation could
preferentially increase the HSAkin17 fraction tightly
associated with DNA. First, experiments were carried out to estimate
the kinetics of induction of the total HSAkin17 protein
content in RKO cells. RKO cells were seeded 3 days before
irradiation and
-irradiated at 50% of confluence to avoid any
effect caused by serum stimulation. Under these conditions, about 25%
of the cells were in S phase as determined by BrdUrd pulse
incorporation and flow cytometry analysis (see Fig. 5A and data not shown). Total proteins were recovered, and the
HSAkin17 protein level was assessed at different times
following irradiation. Although a tremendous induction of p53 was
always observed 6 and 24 h after irradiation, we usually
observed an increased HSAkin17 protein level only 24 and
48 h after irradiation (Fig.
2A). At these times, most of
the RKO cells were arrested in the G2 phase, as evidenced
by flow cytometry (see Fig. 5E and data not shown). Under
these conditions, the PCNA protein level remained unchanged (Fig.
2A).

View larger version (26K):
[in a new window]
Fig. 2.
irradiation increases the
DNA-bound fraction of HSAkin17 protein. RKO cells were
seeded 3 days before irradiation. 24 h after irradiation at the
indicated doses, cells were trypsinized, counted, and frozen.
A, frozen cells were lysed in Laemmli buffer and boiled for
10 min at 100 °C. The equivalent of 33,000 cells was loaded onto a
10% SDS-polyacrylamide gel. B, frozen cells were
lysed in buffer N as indicated under "Materials and Methods."
Detergent-soluble and DNA-bound proteins were collected by
centrifugation (15 min, 20,000 × g) and denatured with
Laemmli buffer. C, R482.1 cells carrying the pEBVCMV vector
were treated as described for A except for lysis. Fresh
extracts were lysed either in buffer N with 0.15, 0.5, or 1 M NaCl or in RIPA buffer. Only soluble proteins were
analyzed by ELISA.
irradiation starting with a dose of 0.5 Gy (Fig.
2B). No significant induction was noted in the
detergent-soluble fraction. Therefore,
irradiation mainly induced
DNA-bound HSAkin17 protein. The p53 protein level increased
in both fractions, suggesting that
irradiation induced both
DNA-bound p53 as well as detergent-soluble p53 (Fig. 2B). We
also noted a slight increase in the PCNA content in the soluble
fraction as well as an increase in the insoluble fraction only at 10 Gy. A similar increase in DNA-bound PCNA protein has already been
reported at doses higher than 10 Gy (28).
Irradiation--
Because several nuclear proteins
involved in DNA repair/DNA damage recognition pathways concentrate into
nuclear foci after irradiation, we performed immunocytochemical
staining using the mAb K36 antibody to determine HSAkin17
sublocalization in RKO cells. The cells were seeded 3 days before
irradiation to avoid serum stimulation of proliferation-associated
proteins such as HSAkin17. In nonirradiated RKO cells,
HSAkin17 showed a weak and diffuse staining pattern
throughout the nucleoplasm (Fig. 3). Twenty-four hours after irradiation, enhanced HSAkin17
protein levels were clearly detected at 2 and 6 Gy. At these times,
HSAkin17 protein coalesces into large foci that might
correspond to the HSAkin17 fraction tightly associated with
DNA.

View larger version (63K):
[in a new window]
Fig. 3.
Detection of HSAkin17 protein
relocalization by indirect immunofluorescence 24 h after
irradiation. RKO cells were seeded 3 days before irradiation and
fixed with acetone/methanol 24 h after irradiation (2 and 6 Gy).
HSAkin17 protein was revealed using the monoclonal antibody
mAb K36 and a Cy2TM-conjugated affinity-purified goat
anti-mouse IgG. Two digitized images of representative cells/dose are
shown at a magnification of 500×.

View larger version (44K):
[in a new window]
Fig. 4.
RKO cells displaying low levels of
HSAkin17 protein fail to accumulate HSAkin17
protein after ionizing radiation. A, 7 weeks after
transfection and selection in the presence of 500 µg/ml hygromycin B,
RASK and R482 cells were fixed, and endogenous HSAkin17 was
revealed using the mAb K36 antibody as described for Fig. 3. The
arrows indicate an extranuclear structure close to the
nuclei. B, 10 weeks after transfection, 0.2 × 0.106 cells were seeded in 6-cm dishes in the presence of
500 µg/ml hygromycin B and irradiated 3 days later at 1.97 Gy/min.
24 h later, the cells were trypsinized, counted, and lysed with
RIPA buffer as indicated under "Materials and Methods." The protein
of 60,000 cells was loaded onto a 10% SDS-polyacrylamide gel.
RASK cells display decreased plating efficiencies and reduced cell
growth


View larger version (69K):
[in a new window]
Fig. 5.
Flow cytometric analysis of BrdUrd
incorporation in RASK.5 cells versus R482.1
cells. The cells were seeded 3 days before irradiation (6 Gy) and
analyzed 24 h later. BrdUrd (30 µM) was added to the
culture medium for 15 min before fixation and labeling with fluorescein
isothiocyanate-conjugated BrdUrd antibody and counterstaining with
propidium iodide as described under "Materials and Methods."
A, C, E, and G, BrdUrd
incorporation is shown as log fluorescence using the FL1-H channel and
relative DNA content (propidium iodide) is measured by FL3-A.
B, D, F, and H, cell cycle
using propidium iodide (FL3-A channel). The experiments were done twice
with the different clones isolated.
-ray-induced G2 arrest (Fig. 5,
F versus H).
Flow cytometry analysis of cells pulse-labeled with BrdUrd
irradiation,
RPA concentrated in nuclear foci of very strong intensity and almost
all the bright RPA foci co-localized with HSAkin17 (Fig. 6,
B and C). These results suggested that
HSAkin17 and RPA could cooperate in response to IR-induced
DNA lesions. However, RPA and HSAkin17 foci of strong
intensity were never detected soon after irradiation at 6 Gy (3 h and
6 h) in proliferating RKO cells nor at later times
post-irradiation in slowly proliferating RKO cells (data not shown).
Co-immunoprecipitation experiments were unsuccessful in
demonstrating a strong physical interaction between endogenous
HSAkin17 and RPA-70 proteins in RKO cells. We assumed that
(i) HSAkin17 and RPA belong to a same high molecular weight complex without direct interaction between them, (ii) only a small fraction of both proteins participate in the same nuclear foci,
and (iii) constitutive amounts of both HSAkin17 and
RPA proteins were too low to be detected under our experimental
conditions.

View larger version (50K):
[in a new window]
Fig. 6.
Co-localization of HSAkin17 and
RPA proteins in response to
rays. RKO
cells were plated 1 day before treatment. Exponentially growing RKO
cells untreated (A) or irradiated at 6 Gy for 24 h
(B and C). Two representative figures are shown
for irradiated cells. Magnification is ×500.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
/
(32). RPA forms discrete foci
after irradiation in many cell lines. The rate of dispersion of
foci-forming proteins is usually compared with the rate of DSB repair.
Kinetic experiments of DSB repair have previously shown a biphasic
response with a fast component for repair of most breaks (half-time
ranging from 20 to 30 min) followed by a slow component for repair of
the remaining breaks (90-300 min) (33). MacPhail and Olive (34) have
shown that the extent of IR-induced RPA foci increased linearly between
8 and 24 h of incubation after irradiation, suggesting that RPA
foci concentrated after the completion of DNA repair at sites of
unrepairable DNA damage. Golub et al. (35) have demonstrated
that RPA co-localized with the DNA recombinational protein Rad51
through its 70-kDa subunit. The highest number of Rad51-RPA
co-localizations was observed 1 day following irradiation (5 Gy) of
mouse fibroblasts. Furthermore, 30 h after irradiation RPA
co-localizes with Rad51 in micronuclei (36). Taken together these data
indicate that RPA foci are associated with unrepaired DNA damage and/or
with DNA sites that are unable to replicate. The idea that a fraction
of HSAkin17 protein co-localized with RPA foci at these
sites of damaged DNA is further supported by the observation that
HSAkin17 protein co-purifies with proteins of the
replication complex of human
cells.5
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Dasika, G. K.,
Lin, S.-C. J.,
Zhao, S.,
Sung, P.,
Tomkinson, A.,
and Lee, E. Y.-H. P.
(1999)
Oncogene
18,
7883-7899[CrossRef][Medline]
[Order article via Infotrieve]
2.
Rothkamm, K.,
Kuhne, M.,
Jeggo, P. A.,
and Lobrich, M.
(2001)
Cancer Res.
61,
3886-3893 3.
Liang, F.,
Han, M.,
Romanienko, P. J.,
and Jasin, M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5172-5177 4.
Maser, R. S.,
Monsen, K. J.,
Nelms, B. E.,
and Petrini, J. H.
(1997)
Mol. Cell. Biol.
17,
6087-6096[Abstract]
5.
Paull, T. T.,
Rogakou, E. P.,
Yamazaki, V.,
Kirchgessner, C. U.,
Gellert, M.,
and Bonner, W. M.
(2000)
Curr. Biol.
10,
886-895[CrossRef][Medline]
[Order article via Infotrieve]
6.
Rogakou, E. P.,
Boon, C.,
Redon, C.,
and Bonner, W. M.
(1999)
J. Cell Biol.
146,
905-916 7.
Schultz, L. B,
Chehab, N. H.,
Malikzay, A.,
and Halazonetis, T. D.
(2000)
J. Cell Biol.
151,
1381-1390 8.
Wang, Y.,
Cortez, D.,
Yazdi, P.,
Neff, N.,
Elledge, S. J.,
and Jun Qin, J.
(2000)
Genes Dev.
14,
927-939 9.
Zhong, Q.,
Chen, C.-F.,
Shang Li, S.,
Chen, Y.,
Wang, C.-C.,
Xiao, J.,
Chen, P.-L.,
Sharp, D. Z.,
and Lee, W.-H.
(1999)
Science.
285,
747-750 10.
Angulo, J. F.,
Moreau, P. L.,
Maunoury, R.,
Laporte, J.,
Hill, A. M.,
Bertolotti, R.,
and Devoret, R.
(1989)
Mutat. Res.
217,
123-134[Medline]
[Order article via Infotrieve]
11.
Angulo, J. F.,
Rouer, E.,
Mazin, A.,
Mattei, M. C.,
Tissier, A.,
Horellou, P.,
Benarous, R.,
and Devoret, R.
(1991)
Nucleic Acids Res.
19,
5117-5123 12.
Kannouche, P.,
Mauffrey, P.,
Pinon-Lataillade, G.,
Mattei, M. G.,
Sarasin, A.,
Daya-Grosjean, L.,
and Angulo, J. F.
(2000)
Carcinogenesis
21,
1701-1710 13.
Kurumizaka, H.,
Aihara, H.,
Ikawa, S.,
Kashima, T.,
Bazemore, L. R.,
Kawasaki, K.,
Sarai, A.,
Radding, C. M.,
and Shibata, T.
(1996)
J. Biol. Chem.
271,
33515-33524 14.
Mermet, N.,
Angulo, J.,
Reperant, J.,
Medina, M.,
and Araneda, S.
(1998)
Neurosci. Lett.
243,
97-100[CrossRef][Medline]
[Order article via Infotrieve]
15.
Araneda, S.,
Mermet, N.,
Verjat, T.,
Angulo, J. F.,
and Radicella, J. P.
(2001)
Brain Res. Bull.
56,
139-146[CrossRef][Medline]
[Order article via Infotrieve]
16.
Mazin, A.,
Milot, E.,
Devoret, R.,
and Chartrand, P.
(1994)
Mol. Gen. Genet.
244,
435-438[Medline]
[Order article via Infotrieve]
17.
Mazin, A.,
Timchenko, T.,
Mènissier-de Murcia, J.,
Schreiber, V.,
Angulo, J. F.,
de Murcia, G.,
and Devoret, R.
(1994)
Nucleic Acids Res.
22,
4335-4341 18.
Timchenko, T.,
Bailone, A.,
and Devoret, R.
(1996)
EMBO J.
15,
3986-3992[Medline]
[Order article via Infotrieve]
19.
Biard, D. S. F.,
Saintigny, Y.,
Maratrat, M.,
Paris, F.,
Martin, M.,
and Angulo, J. F.
(1997)
Radiat. Res.
147,
442-450[Medline]
[Order article via Infotrieve]
20.
Kannouche, P.,
Pinon-Lataillade, G.,
Tissier, A.,
Chevalier-Lagente, O.,
Sarasin, A.,
Mezzina, M.,
and Angulo, J. F.
(1998)
Carcinogenesis
19,
781-789 21.
Blattner, C.,
Kannouche, P.,
Litfin, M.,
Bender, K.,
Rahmsdorf, H. J.,
Angulo, J. F.,
and Herrlich, P.
(2000)
Cell Biol.
20,
3616-3625
22.
Biard, D. S. F.,
Saintigny, Y.,
Maratrat, M.,
Vozenin, M. C.,
Martin, M.,
Daburon, F.,
and Angulo, J.
(1997)
Arch. Dermatol. Res.
289,
448-456[CrossRef][Medline]
[Order article via Infotrieve]
23.
Biard, D. S. F.,
Kannouche, P.,
Lannuzel-Drogou, C.,
Mauffrey, P.,
Apiou, F.,
and Angulo, J. F.
(1999)
Exp. Cell Res.
250,
499-509[CrossRef][Medline]
[Order article via Infotrieve]
24.
Grassi, J.,
Frobert, Y.,
Pradelles, P.,
Chercuitte, F.,
Gruaz, D.,
Dayer, J. Y.,
and Poubelle, P.
(1989)
J. Immunol. Methods
123,
193-210[CrossRef][Medline]
[Order article via Infotrieve]
25.
Göhring, F.,
and Fackelmayer, O.
(1997)
Biochemistry
36,
8276-8283[CrossRef][Medline]
[Order article via Infotrieve]
26.
Bensaad, K.,
Rouillard, D.,
and Soussi, T.
(2001)
Oncogene
20,
3766-3775[CrossRef][Medline]
[Order article via Infotrieve]
27.
Bunz, F.,
Dutriaux, A.,
Lengauer, C.,
Waldman, T.,
Zhou, S.,
Brown, J. P.,
Sedivy, J. M.,
Kinzler, K. W.,
and Vogelstein, B.
(1998)
Science
282,
1497-1501 28.
Balajee, A. S.,
and Geard, C. R.
(2001)
Nucleic Acids Res.
29,
1341-1351 29.
Oakley, G. G.,
Loberg, L. I.,
Yao, J.,
Risinger, M. A.,
Yunker, R. L.,
Zernik-Kobak, M.,
Khanna, K. K.,
Lavin, M. F.,
Carty, M. P.,
and Dixon, K.
(2001)
Mol. Cell. Biol.
12,
1199-1213
30.
Schweizer, U.,
Hey, T.,
Lipps, G.,
and Krauss, G.
(1999)
Nucleic Acids Res.
27,
3183-3189 31.
Wang, M., Mahrenholz, A., and Lee, S.-H. (2000) 39, 6433-6439
32.
Li, L.,
Peterson, C. A.,
Zhang, X.,
and Legerski, R. J.
(2000)
Nucleic Acids Res.
28,
1424-1427 33.
Nunez, M. I.,
Villalobos, M.,
Olea, N.,
Valenzuela, M. T.,
Pedraza, V.,
McMillan, T. J.,
and Ruiz de Almodovar, J. M.
(1995)
Br. J. Cancer
71,
311-316[Medline]
[Order article via Infotrieve]
34.
MacPhail, S. H.,
and Olive, P. L.
(2001)
Radiat. Res.
155,
672-679[CrossRef][Medline]
[Order article via Infotrieve]
35.
Golub, E. I.,
Gupta, R. C.,
Haaf, T.,
Wold, M. S.,
and Radding, C. M.
(1998)
Nucleic Acids Res.
26,
5388-5393 36.
Haaf, T.,
Raderschall, E.,
Reddy, G.,
Ward, D. C.,
Radding, C. M.,
and Golub, E. I.
(2001)
J. Cell Biol.
144,
11-20
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Carlier, J. Couprie, A. le Maire, L. Guilhaudis, I. Milazzo-Segalas, M. Courcon, M. Moutiez, M. Gondry, D. Davoust, B. Gilquin, et al. Solution structure of the region 51 160 of human KIN17 reveals an atypical winged helix domain Protein Sci., December 1, 2007; 16(12): 2750 - 2755. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. F. Biard Untangling the relationships between DNA repair pathways by silencing more than 20 DNA repair genes in human stable clones Nucleic Acids Res., June 28, 2007; 35(11): 3535 - 3550. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Despras, P. Pfeiffer, B. Salles, P. Calsou, S. Kuhfittig-Kulle, J. F. Angulo, and D. S.F. Biard Long-term XPC Silencing Reduces DNA Double-Strand Break Repair Cancer Res., March 15, 2007; 67(6): 2526 - 2534. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S.F. Biard, E. Despras, A. Sarasin, and J. F. Angulo Development of New EBV-Based Vectors for Stable Expression of Small Interfering RNA to Mimick Human Syndromes: Application to NER Gene Silencing Mol. Cancer Res., September 1, 2005; 3(9): 519 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
|